{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:06:12Z","timestamp":1785229572869,"version":"3.55.0"},"reference-count":41,"publisher":"Siapec Servizi Srl","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-936","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:53:24Z","timestamp":1710406404000},"page":"62-68","source":"Crossref","is-referenced-by-count":5,"title":["Pleomorphic\/solid lobular carcinoma of male breast with PALB2 germline mutation: case report and literature review"],"prefix":"10.32074","volume":"116","author":[{"given":"Evelina","family":"Rogges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiberio","family":"Corati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelina","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Farro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"De Toffol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Costarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2024,2]]},"reference":[{"key":"10.32074\/1591-951X-936_ref1","doi-asserted-by":"crossref","unstructured":"Giordano SH. Breast Cancer in Men. N Engl J Med 2018;24:2311-2320. https:\/\/doi.org\/10.1056\/NEJMra170793","DOI":"10.1056\/NEJMra1707939"},{"key":"10.32074\/1591-951X-936_ref2","unstructured":"Key statistics for breast cancer in men: cancer facts & figures 2018. Atlanta: American Cancer Society, 2018 (https:\/\/www.cancer.org\/cancer\/breast-cancer-in-men\/ about\/key-statistics.html)."},{"key":"10.32074\/1591-951X-936_ref3","doi-asserted-by":"crossref","unstructured":"Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population-based study. Cancer 2004;1;101(1):51-7. https:\/\/doi.org\/10.1002\/cncr.20312","DOI":"10.1002\/cncr.20312"},{"key":"10.32074\/1591-951X-936_ref4","doi-asserted-by":"crossref","unstructured":"O\u2019Malley C, Shema S, White E, et al. Incidence of male breast cancer in california, 1988-2000: racial\/ethnic variation in 1759 men. Breast Cancer Res Treat. 2005;93(2):145-50. https:\/\/doi.org\/10.1007\/s10549-005-4517-z.","DOI":"10.1007\/s10549-005-4517-z"},{"key":"10.32074\/1591-951X-936_ref5","doi-asserted-by":"crossref","unstructured":"Brinton LA, Richesson DA, Gierach GL, et al. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst. 2008;15;100(20):1477-81. https:\/\/doi.org\/10.1093\/jnci\/djn329","DOI":"10.1093\/jnci\/djn329"},{"key":"10.32074\/1591-951X-936_ref6","doi-asserted-by":"crossref","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijn J,et al. CHEK2-Breast Cancer Consortium. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet. 2002;31(1):55-9. https:\/\/doi.org\/10.1038\/ng879","DOI":"10.1038\/ng879"},{"key":"10.32074\/1591-951X-936_ref7","doi-asserted-by":"crossref","unstructured":"Ding YC, Steele L, Kuan CJ, Greilac S,et al. Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat. 2011;126(3):771-8. https:\/\/doi.org\/10.1007\/s10549-010-1195-2","DOI":"10.1007\/s10549-010-1195-2"},{"key":"10.32074\/1591-951X-936_ref8","doi-asserted-by":"crossref","unstructured":"Mangone L, Ferrari F, Mancuso P,et al. Epidemiology and biological characteristics of male breast cancer in Italy. Breast Cancer. 2020;27(4):724-731. https:\/\/doi.org\/10.1007\/s12282-020-01068-1","DOI":"10.1007\/s12282-020-01068-1"},{"key":"10.32074\/1591-951X-936_ref9","doi-asserted-by":"crossref","unstructured":"Brinton LA, Key TJ, Kolonel LN, et al. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015;33(18):2041-50. https:\/\/doi.org\/10.1200\/JCO.2014.59.1602","DOI":"10.1200\/JCO.2014.59.1602"},{"key":"10.32074\/1591-951X-936_ref10","doi-asserted-by":"crossref","unstructured":"Brinton LA, Cook MB, McCormack V,et al; European Rare Cancer Study Group; Trichopoulos D, Ursin G, van den Brandt PA, Van Den Eeden SK, Weiderpass E, Willett WC, Ewertz M, Thomas DB. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014;106(3):djt465. https:\/\/doi.org\/10.1093\/jnci\/djt465. Erratum in: J Natl Cancer Inst. 2014;106(5):dju117","DOI":"10.1093\/jnci\/djt465"},{"key":"10.32074\/1591-951X-936_ref11","doi-asserted-by":"crossref","unstructured":"Thomas DB, Jimenez LM, McTiernan A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135(7):734-48. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116360","DOI":"10.1093\/oxfordjournals.aje.a116360"},{"key":"10.32074\/1591-951X-936_ref12","doi-asserted-by":"crossref","unstructured":"Brinton LA, Carreon JD, Gierach GL, et al. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat. 2010;119(1):185-92. https:\/\/doi.org\/10.1007\/s10549-009-0379-0","DOI":"10.1007\/s10549-009-0379-0"},{"key":"10.32074\/1591-951X-936_ref13","unstructured":"Hultborn R, Hanson C, K\u00f6pf I, et al. Prevalence of Klinefelter\u2019s syndrome in male breast cancer patients. Anticancer Res. 1997;17(6D):4293-7"},{"key":"10.32074\/1591-951X-936_ref14","doi-asserted-by":"crossref","unstructured":"Pritzlaff M, Summerour P, McFarland R, et al. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat. 2017;161(3):575-586. doi:10.1007\/s10549-016-4085-4","DOI":"10.1007\/s10549-016-4085-4"},{"key":"10.32074\/1591-951X-936_ref15","doi-asserted-by":"crossref","unstructured":"Carnevali I, Tedaldi G, Pensotti V, et al. Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes. Front Oncol. 2022;12:891426. https:\/\/doi.org\/10.3389\/fonc.2022.891426","DOI":"10.3389\/fonc.2022.891426"},{"key":"10.32074\/1591-951X-936_ref16","doi-asserted-by":"crossref","unstructured":"Saggini A, R\u00fctten A. Cutaneous Involvement by Pleomorphic Lobular Carcinoma of the Male Breast: An Exceptional Occurrence. Am J Dermatopathol. 2020;42(11):895-896. https:\/\/doi.org\/10.1097\/DAD.0000000000001657","DOI":"10.1097\/DAD.0000000000001657"},{"key":"10.32074\/1591-951X-936_ref17","unstructured":"Ishida M, Mori T, Umeda T, et al. Pleomorphic lobular carcinoma in a male breast: a case report with review of the literature. Int J Clin Exp Pathol. 2013;6(7):1441-4"},{"key":"10.32074\/1591-951X-936_ref18","unstructured":"Murzabdillaeva A, Ali Y, Aakash N, et al. Pleomorphic Invasive Lobular Carcinoma of the Male Breast: Two Case Reports with Opposite Hormone Receptor Status. Ann Clin Lab Sci. 2019;49(4):534-538"},{"key":"10.32074\/1591-951X-936_ref19","doi-asserted-by":"crossref","unstructured":"Zahir MN, Minhas K, Shabbir-Moosajee M. Pleomorphic lobular carcinoma of the male breast with axillary lymph node involvement: a case report and review of literature. BMC Clin Pathol. 2014;14:16. https:\/\/doi.org\/10.1186\/1472-6890-14-16","DOI":"10.1186\/1472-6890-14-16"},{"key":"10.32074\/1591-951X-936_ref20","doi-asserted-by":"crossref","unstructured":"Rohini B, Singh PA, Vatsala M, et al. Pleomorphic lobular carcinoma in a male breast: a rare occurrence. Patholog Res Int. 2010;2010:871369. https:\/\/doi.org\/10.4061\/2010\/871369","DOI":"10.4061\/2010\/871369"},{"key":"10.32074\/1591-951X-936_ref21","doi-asserted-by":"crossref","unstructured":"Maly B, Maly A, Pappo I, et al. Pleomorphic variant of invasive lobular carcinoma of the male breast. Virchows Arch. 2005;446(3):344-5. https:\/\/doi.org\/10.1007\/s00428-004-1179-x","DOI":"10.1007\/s00428-004-1179-x"},{"key":"10.32074\/1591-951X-936_ref22","doi-asserted-by":"crossref","unstructured":"Costa M, Costeira B, Fonseca R, et al. Invasive Pleomorphic Lobular Carcinoma of The Male Breast: A Rare Diagnosis with Radiologic-Pathologic Correlation. Acta Med Port. 2022;35(11):840-844. https:\/\/doi.org\/10.20344\/amp.17206","DOI":"10.20344\/amp.17206"},{"key":"10.32074\/1591-951X-936_ref23","doi-asserted-by":"crossref","unstructured":"Wolff AC, Hammond MEH, Allison KH, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol. 2018;36(20):2105-2122. https:\/\/doi.org\/10.1200\/JCO.2018.77.8738","DOI":"10.1200\/JCO.2018.77.8738"},{"key":"10.32074\/1591-951X-936_ref24","unstructured":"Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual. 8th edition. Springer International Publishing: American Joint Commission on Cancer; 2017."},{"key":"10.32074\/1591-951X-936_ref25","doi-asserted-by":"crossref","unstructured":"Christgen M, Cserni G, Floris G, et al. Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors. Cancers (Basel). 2021;13(15):3695. https:\/\/doi.org\/10.3390\/cancers13153695.","DOI":"10.3390\/cancers13153695"},{"key":"10.32074\/1591-951X-936_ref26","doi-asserted-by":"crossref","unstructured":"Eusebi V, Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol. 1992;23(6):655-62. https:\/\/doi.org\/10.1016\/0046-8177(92)90321-s","DOI":"10.1016\/0046-8177(92)90321-S"},{"key":"10.32074\/1591-951X-936_ref27","doi-asserted-by":"crossref","unstructured":"Ohashi R, Matsubara M, Watarai Y, et al. Pleomorphic lobular carcinoma of the breast: a comparison of cytopathological features with other lobular carcinoma variants. Cytopathology. 2017;28(2):122-130. https:\/\/doi.org\/10.1111\/cyt.12362","DOI":"10.1111\/cyt.12362"},{"key":"10.32074\/1591-951X-936_ref28","doi-asserted-by":"crossref","unstructured":"Gao Y, Heller SL, Moy L. Male Breast Cancer in the Age of Genetic Testing: An Opportunity for Early Detection, Tailored Therapy, and Surveillance. Radiographics. 2018;38(5):1289-1311. doi:10.1148\/rg.2018180013","DOI":"10.1148\/rg.2018180013"},{"key":"10.32074\/1591-951X-936_ref29","doi-asserted-by":"crossref","unstructured":"Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer [published correction appears in Lancet. 2006 Jun 3;367(9525):1818]. Lancet. 2006;367(9510):595-604. doi:10.1016\/S0140-6736(06)68226-3","DOI":"10.1016\/S0140-6736(06)68226-3"},{"key":"10.32074\/1591-951X-936_ref30","doi-asserted-by":"crossref","unstructured":"Rizzolo P, Zelli V, Silvestri V, et al. Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy [published correction appears in Int J Cancer. 2020 Jul 15;147(2):E2]. Int J Cancer. 2019;145(2):390-400. doi:10.1002\/ijc.32106","DOI":"10.1002\/ijc.32106"},{"key":"10.32074\/1591-951X-936_ref31","doi-asserted-by":"crossref","unstructured":"Bouras A, Lafaye C, Leone M, et al. Identification and Characterization of an Exonic Duplication in PALB2 in a Man with Synchronous Breast and Prostate Cancer. Int J Mol Sci. 2022;23(2):667. Published 2022 Jan 8. doi:10.3390\/ijms23020667","DOI":"10.3390\/ijms23020667"},{"key":"10.32074\/1591-951X-936_ref32","doi-asserted-by":"crossref","unstructured":"Yang X, Leslie G, Doroszuk A, et al. Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J. Clin. Oncol. 38, 674\u2013685 (2020)","DOI":"10.1200\/JCO.19.01907"},{"key":"10.32074\/1591-951X-936_ref33","doi-asserted-by":"crossref","unstructured":"Antoniou AC, Casadei S, Heikkinen T, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497-506. doi:10.1056\/NEJMoa1400382","DOI":"10.1056\/NEJMc1410673"},{"key":"10.32074\/1591-951X-936_ref34","doi-asserted-by":"crossref","unstructured":"Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. N Engl J Med. 2021;384(5):428-439. doi:10.1056\/NEJMoa1913948","DOI":"10.1056\/NEJMoa1913948"},{"key":"10.32074\/1591-951X-936_ref35","doi-asserted-by":"crossref","unstructured":"Tischkowitz M, Balma\u00f1a J, Foulkes WD, et al. Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(8):1416-1423. doi:10.1038\/s41436-021-01151-8","DOI":"10.1038\/s41436-021-01151-8"},{"key":"10.32074\/1591-951X-936_ref36","doi-asserted-by":"crossref","unstructured":"Pensabene M, Von Arx C, De Laurentiis M. Male Breast Cancer: From Molecular Genetics to Clinical Management. Cancers (Basel). 2022;14(8):2006. https:\/\/doi.org\/10.3390\/cancers14082006","DOI":"10.3390\/cancers14082006"},{"key":"10.32074\/1591-951X-936_ref37","doi-asserted-by":"crossref","unstructured":"Slater EP, Langer P, Niemczyk E, et al. PALB2 mutations in European familial pancreatic cancer families. Clin Genet. 2010; 78(5):490-4. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01425.x","DOI":"10.1111\/j.1399-0004.2010.01425.x"},{"key":"10.32074\/1591-951X-936_ref38","doi-asserted-by":"crossref","unstructured":"Bogdanova N, Sokolenko AP, Iyevleva AG, et al. PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat. 2011; 126(2):545-50. https:\/\/doi.org\/10.1007\/s10549-010-1290-4","DOI":"10.1007\/s10549-010-1290-4"},{"key":"10.32074\/1591-951X-936_ref39","doi-asserted-by":"crossref","unstructured":"Janatova M, Kleibl Z, Stribrna J, et al. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2323-32. https:\/\/doi.org\/10.1158\/1055-9965","DOI":"10.1158\/1055-9965.EPI-13-0745-T"},{"key":"10.32074\/1591-951X-936_ref40","doi-asserted-by":"crossref","unstructured":"Casadei S, Norquist BM, Walsh T, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res. 2011;71(6):2222-9. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3958","DOI":"10.1158\/0008-5472.CAN-10-3958"},{"key":"10.32074\/1591-951X-936_ref41","doi-asserted-by":"crossref","unstructured":"Kanchi KL, Johnson KJ, Lu C, et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun. 2014;5:3156. https:\/\/doi.org\/10.1038\/ncomms4156","DOI":"10.1038\/ncomms4156"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:27:52Z","timestamp":1730813272000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-936","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"article-number":"7"}}